Skip to main content

Pelvic Venous Disorders (PeVD) and Pelvic Congestion Syndrome

Pelvic venous disorders (PeVD) encompass a spectrum of conditions caused by pelvic venous reflux, obstruction, or both. Their best-characterized clinical phenotype — pelvic congestion syndrome (PCS) / pelvic venous insufficiency (PVI) — is implicated in up to 30% of chronic pelvic pain (CPP) presentations in women and remains substantially underdiagnosed.[12] For the urogynecologist and reconstructive urologist, PeVD matters for three reasons: (1) it is a treatable, often-missed cause of CPP that should be excluded before attributing pain to a primary urologic, gynecologic, or myofascial source; (2) the gonadal and internal iliac venous outflow shares surgical real estate with the ureter, pelvic plexus, and uterine vasculature, so PeVD anatomy is directly relevant to radical hysterectomy, uterine transplantation, and complex pelvic floor reconstruction; and (3) recent data link PeVD to postural orthostatic tachycardia syndrome (POTS), reframing some "dysautonomia" presentations as compensatory responses to mechanical venous obstruction.[29]

For the broader differential of pelvic pain, see Chronic Pelvic Pain.

Normal Pelvic Venous Anatomy​

The female pelvic venous system is highly interconnected and variable between patients, with rich collateral potential that has both protective and diagnostic implications.[1][2]

Principal drainage pathways​

  • Ovarian (gonadal) veins. Drain the ovaries, fallopian tubes, and superior uterus. The left ovarian vein drains into the left renal vein; the right ovarian vein drains directly into the IVC, typically within 25 mm below the right renal vein ostium.[3] The longer left ovarian vein column and its perpendicular insertion into the renal vein predispose to reflux and congestion on the left.[4][5]
  • Uterine (inferior uterine) veins. Drain the inferior uterus and cervix; course laterally through the base of the broad ligament to the internal iliac veins. Typically plexiform.[6]
  • Utero-ovarian arcade. Anastomotic connection between uterine and ovarian systems with caliber similar to both (~3.7 mm), suggesting the internal genital organs function as a venous pool without preferential drainage.[2]
  • Internal iliac veins. Receive uterine, vaginal plexus, vesical plexus, and rectal plexus drainage; tributaries include obturator, gluteal, and pudendal veins.[1]
  • Ramus communicans. A cross-pelvic anastomosis between the left and right parametrial plexuses enabling contralateral drainage.[2]
  • Fallopian tube drainage. Via three separate veins (internal, median, external tubal).[2]

Embryologic basis for left/right asymmetry​

The pelvic venous system derives from the caudal cardinal veins (CCVs) during weeks 4–10. The infrarenal IVC develops from the right CCV; the renal segment arises from subcardinal veins; the iliac veins form by gradual caudal CCV extension.[18][19] Regression of left-sided embryonic conduits with preservation of right-sided structures explains why the left gonadal vein takes the long, perpendicular renal-vein route and why left-sided compression syndromes (nutcracker, May-Thurner) predominate.

The deep uterine vein (DUV) — surgical landmark​

The deep uterine vein arises from the merger of cervical, vesical, and vaginal veins, courses through the paracervix in a descending/posterior direction, and drains into the internal iliac vein.[20] Cadaveric studies have identified an inconstant duality — a larger-caliber deep uterine vein with a separate superficial uterine vein — in approximately 25% of cases.[21]

The DUV is operatively critical because it divides the lateral uterine aspect into two zones: a superior vascular zone (uterine artery, ureter) and an inferior nervous zone (autonomic pathway / inferior hypogastric plexus).[20][22] Early identification of the DUV–pelvic splanchnic nerve crossing point during radical hysterectomy enables nerve-sparing dissection and reduces intraoperative bleeding.[22][23] In uterine transplantation, the spatial relationship of the DUV with the ureter (passing posterior to the superficial uterine vein and anterior to the DUV) and the inferior hypogastric plexus is an indispensable guide for safe graft procurement.[21]

Uterine venous nomenclature for transplantation​

The US Uterus Transplant Consortium has proposed a standardized nomenclature renaming the four veins originating from the uterus as superior and inferior uterine veins:[6]

  • Inferior uterine veins — drain the inferior uterus, plexiform, course laterally through the broad ligament base to the internal iliac veins (equivalent to conventional "uterine veins").
  • Superior uterine veins — drain the superior uterus to the ovaries through the suspensory ligament (previously lumped with "ovarian veins" but functionally distinct).

Collateral pathways​

PathwayComponents
DeepLumbar veins, sacral veins, vertebral venous plexuses
SuperficialCircumflex iliac, epigastric vessels
IntermediateGonadal veins, ovarian / uterine plexuses
IliofemoralVarious pathways bypassing iliac obstruction
PortosystemicActivated only in severe / chronic obstruction

Pathophysiology​

PeVD is classified into two principal mechanisms (which frequently coexist):[7][8]

  1. Primary venous reflux — most commonly involving the ovarian veins from incompetent valves. Left ovarian vein reflux is identified in 100% of patients with symptomatic pelvic varices versus 25% of controls.[5][9] Critically, passive left renal vein → left gonadal vein reflux occurs in up to 38% of asymptomatic women, so reflux on imaging alone is insufficient for diagnosis.[5]
  2. Secondary venous obstruction — two classic entities:
    • Nutcracker syndrome — compression of the left renal vein between the aorta and superior mesenteric artery, with elevated pressure transmitted to the left ovarian vein.[10][11]
    • May-Thurner (iliac vein compression) syndrome — compression of the left common iliac vein by the overlying right common iliac artery, with reflux into the ipsilateral internal iliac vein.[10][11]

Hormonal contribution​

Hormonal milieu is a major modifier of pelvic venous distensibility:

  • Estrogen. High endogenous estradiol is independently associated with increased venous distensibility and clinical varicose veins (OR 3.6, 95% CI 1.1–11.6; venous distensibility OR 4.4, 95% CI 1.2–15.5 in menopausal women). Both ER and PR are expressed in saphenous vein walls.[24]
  • Progesterone and pregnancy. Progesterone relaxes venous smooth muscle, the gravid uterus exerts mechanical compression, and circulating volume rises 40–50%. 70–80% of pregnancy-related varicose veins appear in the first trimester, often within 2–3 weeks of conception.[25] Uterine blood flow during gestation pushes valve leaflets apart, enabling retrograde flow that may persist postpartum and worsen with each successive pregnancy.[26]
  • Postmenopausal pattern. The premenopausal-parous predominance of PCS, with relative postmenopausal rarity, supports the hormonal hypothesis.[8]

Clinical Presentation​

PCS occurs predominantly in premenopausal parous women, although nulliparous patients are well-described.[12][15] Cardinal features:

  • Dull, aching pelvic pain worsened by prolonged standing, intercourse, and the premenstrual period.
  • Post-coital pain — often described as pathognomonic.[12]
  • Dyspareunia, dysmenorrhea, dysuria.
  • Vulvar and perivulvar varicosities (especially post-pregnancy) — present in 22–34% of women with pelvic varices and 18–22% of pregnant women.[28]
  • Urologic symptoms: hematuria and urinary frequency in the absence of infection.[13][14]
  • Lower extremity varicose veins of pelvic origin (posteromedial thigh, vulva).

Imaging prevalence anchors. CT demonstrates ovarian vein dilation (≥ 6 mm) in approximately 13.7% of women aged 25–65, most commonly bilateral.[4] Chronic pelvic pain of unclear etiology with dilated veins was documented in 8% of premenopausal women in a large imaging series.[14]

Pelvic escape points and extra-pelvic varicose veins​

Reflux from the pelvis can manifest in the leg via four recognized escape points:[9][27]

Escape pointRouteClinical signature
InguinalRound ligament → groin / vulvaVulvar / labial varix
ObturatorObturator canal → medial thighMedial-thigh varicose veins
PerinealDirect to vulva / perineumPerineal varix
GlutealGreater sciatic foramen → posterior thigh / buttockPosterior-thigh varix; can include intra/peri-neural (sciatic, tibial) varices from inferior gluteal tributary

Notably, most patients with extra-pelvic varicose veins of pelvic origin do not report pelvic symptoms — only 7% had CPP in a series of 72 symptomatic patients.[28] A "bottom-up" treatment approach (US-guided foam sclerotherapy or ligation of escape points and extra-pelvic varicosities) is often sufficient as first-line therapy; ovarian vein embolization or iliac vein stenting is reserved for failure or development of pelvic symptoms.[27]

Classification — The SVP System​

The American Vein & Lymphatic Society Symptoms-Varices-Pathophysiology (SVP) classification standardizes nomenclature for PeVD, complementing the CEAP system used for lower-extremity venous disease.[9] The pelvis is partitioned into four anatomic zones:

ZoneAnatomy
Zone 1Left renal vein
Zone 2Gonadal and internal iliac veins; pelvic venous plexuses
Zone 3Pelvic-origin extra-pelvic transitional veins (escape points)
Zone 4Lower extremity veins (classified per CEAP)

SVP notation is structured as S (symptoms) V (varices) P (pathophysiology), with P incorporating Anatomy, Hemodynamics, and Etiology as subscripts.[9]

ExampleSVP notation
Bilateral ovarian reflux with pelvic painS₂V₂P(BGV,R,NT)
Nutcracker syndromeS₁V₁P(LRV,O,NT)
May-Thurner syndromeS₀V₀P(LCIV,O,NT)

Diagnosis​

Pelvic venous engorgement and gonadal vein reflux can be seen in asymptomatic women, so imaging findings must be correlated with the clinical syndrome.[5][10]

Imaging hierarchy​

ModalityRoleKey criteria / yield
Transvaginal US (TVUS)First-lineOvarian vein > 7–8 mm, flow velocity < 3 cm/s, dilated pelvic veins > 5 mm; ~96% correlation with venography[12][16]
Catheter venographyHistoric gold standardDirect visualization of reflux; pressure measurements[10][17]
CT / MRIStructural causes; planningNutcracker / May-Thurner anatomy; ovarian vein grading on CT — mild (< 6 mm), moderate (6–8 mm), severe (> 8 mm)[4]
IVUSIncreasingly the true gold standard for venous stenosisDetects significant lesions in 26.3% of patients with negative 3-view venography[31]
LaparoscopyLow sensitivityCO₂ pneumoperitoneum and Trendelenburg compress pelvic veins[12]

Intravascular ultrasound — diagnostic upgrade​

IVUS is increasingly considered the true gold standard for venous stenosis evaluation, surpassing conventional venography:[30][31]

  • For non-thrombotic iliac vein lesions, duplex US sensitivity/specificity is 58% / 30%, MRV 90% / 40%, venography 95% / 95%; IVUS detected significant lesions in 26.3% of patients with negative 3-view venography.[31]
  • The VIDIO trial (Venogram vs. IVUS for Diagnosing Iliac Vein Obstruction) showed IVUS enhances stenosis localization, reference-vessel sizing for stent selection, and post-deployment expansion assessment.[30][32]
  • The SCAI/AVF/AVLS/SIR/SVM/SVS multidisciplinary expert opinion supports IVUS as essential for procedural planning during deep venous intervention.[30]
  • Up to 10% of significant stenotic lesions remain occult on IVUS and require trial balloon angioplasty to unmask.[31]

Management​

Treatment is directed at the underlying mechanism — reflux, obstruction, or both. When both coexist, the obstruction is treated first before considering gonadal vein embolization.[10][11]

Medical therapy​

Medroxyprogesterone acetate or GnRH agonists may produce short-term pain reduction by suppressing ovarian function; long-term efficacy is unproven.[13]

Endovascular interventions (mainstay)​

  • Ovarian / pelvic vein embolization (coils, plugs, sclerosant) is the standard approach for primary reflux. Technical success approaches 100%, with mean VAS pain reduction from 8.5 → 2.4 at 90 days and 90% satisfaction in a nulliparous-only series.[13][15]
  • Iliac vein stenting for May-Thurner; left renal vein balloon angioplasty for nutcracker. Combined approaches (angioplasty + stenting + embolization) yield significant NRS reduction and QoL improvement.[11]
  • The first patient-blinded RCT of transvenous occlusion of incompetent pelvic veins (n = 60) at 12 months showed:[33]
    • Median SF-MPQ pain 2 vs. 9 (p = 0.016)
    • VAS pain 15 vs. 53 (p = 0.002)
    • EQ-5D QoL 0.79 → 0.84 (p = 0.008)
    • No major complications
  • A 2025 prospective study of 40 women with venous-origin CPP (VO-CPP) treated with coil + foam embolization demonstrated sustained relief at mean 29.6-month follow-up, with no significant difference between mid- and long-term scores; 81% patient satisfaction, 86% willing to repeat.[34]
  • Systematic review of 21 prospective case series (1,308 women) — early substantial pain relief in ~75%, generally increasing and sustained over time, with durability up to 5 years.[35]

Surgical options​

Hysterectomy with oophorectomy and ovarian vein ligation/excision are reserved for patients refractory to embolization/stenting and are uncommonly performed in the endovascular era.[13]

Emerging Association: PeVD and POTS / Orthostatic Intolerance​

A 2026 retrospective Emory series identified an 83% prevalence of PeVD among patients with postural orthostatic tachycardia syndrome / orthostatic intolerance (POTS/OI).[29] The proposed mechanism: iliac vein compression → impeded venous outflow → elevated pelvic venous pressure → reduced central venous return → compensatory tachycardia.

Following iliac vein stenting in patients with both PeVD and POTS/OI, 44% had complete resolution of orthostatic symptoms and 71% had significant clinical improvement at one year.[29] This finding has prompted a reframing of POTS pathophysiology — for a meaningful subset of patients, the orthostatic tachycardia may be a compensatory response to structural venous obstruction rather than primary autonomic failure, with therapeutic implications favoring mechanical treatment of the venous obstruction over heart-rate suppression.[36]

Practical Notes for the Reconstructive Urologist / Urogynecologist​

  • Always consider PeVD in CPP with post-coital pain, vulvar varices, or a CT incidentally showing a dilated left ovarian vein. Refer for TVUS with venous Doppler protocol rather than dismissing as a CT artifact.
  • Imaging alone does not diagnose PeVD — reflux is present in up to 38% of asymptomatic women.[5] The diagnosis is clinical-radiologic.
  • Treat obstruction before reflux when both are present.[10][11]
  • The DUV is a surgical landmark, not just a venographic finding — anatomic literacy of the paracervical venous plexus protects the ureter and inferior hypogastric plexus during radical hysterectomy and uterine transplantation.[20][21][22]
  • POTS / orthostatic-intolerance comorbidity is a flag, not a confounder — these patients may be undertreated PeVD candidates rather than primary dysautonomia.[29][36]

References​

1. Zurcher KS, Staack SO, Spencer EB, et al. "Venous anatomy and collateral pathways of the pelvis: an angiographic review." Radiographics. 2022;42(5):1532–1545. doi:10.1148/rg.220012

2. Pavkov ML, Koebke J, Notermans HP, Brökelmann J. "Quantitative evaluation of the utero-ovarian venous pattern in the adult human female cadaver with plastination." World J Surg. 2004;28(2):201–205. doi:10.1007/s00268-003-7022-8

3. Barber B, Horton A, Patel U. "Anatomy of the origin of the gonadal veins on CT." J Vasc Interv Radiol. 2012;23(2):211–215. doi:10.1016/j.jvir.2011.10.013

4. Szaflarski D, Sosner E, French TD, et al. "Evaluating the frequency and severity of ovarian venous congestion on adult computed tomography." Abdom Radiol (NY). 2019;44(1):259–263. doi:10.1007/s00261-018-1707-9

5. Nascimento AB, Mitchell DG, Holland G. "Ovarian veins: magnetic resonance imaging findings in an asymptomatic population." J Magn Reson Imaging. 2002;15(5):551–556. doi:10.1002/jmri.10098

6. Johannesson L, Testa G, Flyckt R, et al. "Guidelines for standardized nomenclature and reporting in uterus transplantation: an opinion from the United States Uterus Transplant Consortium." Am J Transplant. 2020;20(12):3319–3325. doi:10.1111/ajt.15973

7. Barge TF, Uberoi R. "Symptomatic pelvic venous insufficiency: a review of the current controversies in pathophysiology, diagnosis, and management." Clin Radiol. 2022;77(6):409–417. doi:10.1016/j.crad.2022.01.053

8. Bałabuszek K, Toborek M, Pietura R. "Comprehensive overview of the venous disorder known as pelvic congestion syndrome." Ann Med. 2022;54(1):22–36. doi:10.1080/07853890.2021.2014556

9. Meissner MH, Khilnani NM, Labropoulos N, et al. "The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: a report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders." J Vasc Surg Venous Lymphat Disord. 2021;9(3):568–584. doi:10.1016/j.jvsv.2020.12.084

10. Bookwalter CA, VanBuren WM, Neisen MJ, Bjarnason H. "Imaging appearance and nonsurgical management of pelvic venous congestion syndrome." Radiographics. 2019;39(2):596–608. doi:10.1148/rg.2019180159

11. Wu WC, Hsu WH, Chang TC, Huang LW. "Pelvic congestion syndrome due to central venous outflow obstruction: a single-center experience with May-Thurner and nutcracker syndromes." Int J Gynaecol Obstet. 2025. doi:10.1002/ijgo.70268

12. Krambeck C, Tesch K, Watrowski R, Maass N, Alkatout I. "Pelvic congestion syndrome: the gynecological perspective." J Clin Med. 2026;15(4):1655. doi:10.3390/jcm15041655

13. Gloviczki P, Comerota AJ, Dalsing MC, et al. "The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum." J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi:10.1016/j.jvs.2011.01.079

14. Jurga-Karwacka A, Karwacki GM, Schoetzau A, et al. "A forgotten disease: pelvic congestion syndrome as a cause of chronic lower abdominal pain." PLoS One. 2019;14(4):e0213834. doi:10.1371/journal.pone.0213834

15. Szmygin M, Pyra K, Bèrczi V, et al. "Endovascular treatment of pelvic venous congestion syndrome in nulliparous patients — preliminary results of 10 years of experience." Cardiovasc Intervent Radiol. 2024;47(6):822–828. doi:10.1007/s00270-024-03731-y

16. Szkodziak F, Woźniak S, Kudła M, et al. "The usefulness of transvaginal ultrasonography in the diagnosis of pelvic venous disorders." Sci Rep. 2025;15(1):24776. doi:10.1038/s41598-025-10311-8

17. Knuttinen MG, Machan L, Khilnani NM, et al. "Diagnosis and management of pelvic venous disorders: expert panel narrative review." AJR Am J Roentgenol. 2023;221(5):565–574. doi:10.2214/AJR.22.28796

18. Hikspoors JP, Mekonen HK, Mommen GM, et al. "Infrahepatic inferior caval and azygos vein formation in mammals with different degrees of mesonephric development." J Anat. 2016;228(3):495–510. doi:10.1111/joa.12423

19. Hikspoors JP, Soffers JH, Mekonen HK, et al. "Development of the human infrahepatic inferior caval and azygos venous systems." J Anat. 2015;226(2):113–125. doi:10.1111/joa.12266

20. Robin F, Roux L, Zaheer MA, et al. "A reappraisal of the deep uterine vein: a multimodal exploration with implications for pelvic surgery." Surg Radiol Anat. 2024;46(3):381–390. doi:10.1007/s00276-024-03316-x

21. Robin F, Dion L, Lavoue V, et al. "Relationship between uterine veins, ureter, and hypogastric nerve for uterine transplantation: an anatomic study." Clin Anat. 2022;35(8):1026–1032. doi:10.1002/ca.23850

22. Horie A, Abiko K, Baba T, et al. "A novel direct approach to the deep uterine vein in laparoscopic radical hysterectomy." J Minim Invasive Gynecol. 2021;28(8):1444–1445. doi:10.1016/j.jmig.2020.12.018

23. Yuan L, Dong X, Chen M, Yao L. "A vascular centered surgical approach to radical hysterectomy: laparoscopic anatomy of pelvic vascular system revisited." J Minim Invasive Gynecol. 2023;30(9):692. doi:10.1016/j.jmig.2023.06.006

24. Ciardullo AV, Panico S, Bellati C, et al. "High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women." J Vasc Surg. 2000;32(3):544–549. doi:10.1067/mva.2000.107768

25. Smyth RM, Aflaifel N, Bamigboye AA. "Interventions for varicose veins and leg oedema in pregnancy." Cochrane Database Syst Rev. 2015;(10):CD001066. doi:10.1002/14651858.CD001066.pub3

26. Riding DM, Hansrani V, McCollum C. "Pelvic vein incompetence: clinical perspectives." Vasc Health Risk Manag. 2017;13:439–447. doi:10.2147/VHRM.S132827

27. Jaworucka-Kaczorowska A, Roustazadeh R, Simka M, Jalaie H. "Management of extra-pelvic varicose veins of pelvic origin in female patients." J Clin Med. 2025;14(8):2707. doi:10.3390/jcm14082707

28. Gloviczki P, Lawrence PF, Wasan SM, et al. "The 2023 SVS, AVF, and AVLS clinical practice guidelines for the management of varicose veins of the lower extremities. Part II." J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. doi:10.1016/j.jvsv.2023.08.011

29. Spencer EB, Elhage Hassan M, Saikia J, et al. "Association and post-iliac vein stenting symptom improvement of postural orthostatic tachycardia syndrome and orthostatic intolerance with pelvic venous disorders: two retrospective studies." EClinicalMedicine. 2026;92:103772. doi:10.1016/j.eclinm.2026.103772

30. Secemsky EA, Aronow HD, Kwolek CJ, et al. "Intravascular ultrasound use in peripheral arterial and deep venous interventions: multidisciplinary expert opinion from SCAI/AVF/AVLS/SIR/SVM/SVS." J Soc Cardiovasc Angiogr Interv. 2024;3(1):101205. doi:10.1016/j.jscai.2023.101205

31. Rochon PJ, Reghunathan A, Kapoor BS, et al. "ACR Appropriateness Criteria® lower extremity chronic venous disease." J Am Coll Radiol. 2023;20(11S):S481–S500. doi:10.1016/j.jacr.2023.08.011

32. Vedantham S, Desai KR, Weinberg I, et al. "Society of Interventional Radiology position statement on the endovascular management of acute iliofemoral deep vein thrombosis." J Vasc Interv Radiol. 2023;34(2):284–299.e7. doi:10.1016/j.jvir.2022.10.038

33. Hansrani V, Riding D, Seif MW, et al. "Transvenous occlusion of incompetent pelvic veins to treat chronic pelvic pain in women: a randomised controlled trial." BJOG. 2023;130(11):1362–1369. doi:10.1111/1471-0528.17512

34. Bałabuszek K, Toborek M, Pietura R. "Symptoms and quality of life assessment after coil and foam embolization in patients with venous-origin chronic pelvic pain (VO-CPP) — a subgroup of pelvic venous disorders (PeVD)." Ann Med. 2025;57(1):2570798. doi:10.1080/07853890.2025.2570798

35. Daniels JP, Champaneria R, Shah L, et al. "Effectiveness of embolization or sclerotherapy of pelvic veins for reducing chronic pelvic pain: a systematic review." J Vasc Interv Radiol. 2016;27(10):1478–1486.e8. doi:10.1016/j.jvir.2016.04.016

36. Chopra P. "Postural orthostatic tachycardia syndrome: when dysautonomia misleads — a mechanistic argument for compensatory orthostatic tachycardia." Front Neurol. 2026;17:1806502. doi:10.3389/fneur.2026.1806502